Mutational Analysis of the MEFV Gene in Egyptian Patients with Familial Mediterranean Fever
Aim: Familial Mediterranean fever is an autosomal recessive disease affecting primarily populations surrounding the Mediterranean basin. The aim of this study was to find the distribution of MEFV gene mutations in a group of Egyptian patients with FMF and to evaluate any predictive genotype-phenotype correlation in this group of patients. Materials and Methods: The study included 112 patients (59 males and 53 females). Sequencing of the exon 10, exon 3, and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the MEFV gene were performed for all the patients according to a previously described technique. Results: Mutations in the MEFV gene were identified in 63 patients (56.25%). The most common mutation was M694I, which was detected in 9.8%, followed by V726A in 7.1%, E148Q in 5.8%, R202Q in 4.9%, M694V in 4.5%, M680I(G/C) in 3.1%, M680I(G/A) in 3.1%, and P706 in 2.6% of studied chromosomes. Conclusions: The mutation spectrum in Egyptian patients with FMF is heterogeneous. R202Q and P706 might be disease-causing mutations and should be further investigated in more patients in different populations.
Mutational Analysis of the MEFV Gene in Egyptian Patients with Familial Mediterranean Fever
Aim: Familial Mediterranean fever is an autosomal recessive disease affecting primarily populations surrounding the Mediterranean basin. The aim of this study was to find the distribution of MEFV gene mutations in a group of Egyptian patients with FMF and to evaluate any predictive genotype-phenotype correlation in this group of patients. Materials and Methods: The study included 112 patients (59 males and 53 females). Sequencing of the exon 10, exon 3, and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the MEFV gene were performed for all the patients according to a previously described technique. Results: Mutations in the MEFV gene were identified in 63 patients (56.25%). The most common mutation was M694I, which was detected in 9.8%, followed by V726A in 7.1%, E148Q in 5.8%, R202Q in 4.9%, M694V in 4.5%, M680I(G/C) in 3.1%, M680I(G/A) in 3.1%, and P706 in 2.6% of studied chromosomes. Conclusions: The mutation spectrum in Egyptian patients with FMF is heterogeneous. R202Q and P706 might be disease-causing mutations and should be further investigated in more patients in different populations.
___
- 1. El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet 2006; 367: 1016-24.
- 2. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 1986; 314: 1001-1005.
- 3. French FMF Consortium. A candidate gene for Familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
- 4. International FMF Consortium. Ancient missense mutations in a new member of the Roret gene family are likely to cause familial Mediterranean fever. Cell 1997; 19: 797-807.
- 5. Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM, Askentijevich I et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 2001; 98: 851-859.
- 6. Centola M, Aksentijevich.I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581-1588.
- 7. http://fmf.igh.cnrs.fr/ISSAID/infevers/search.php.
- 8. Chaabouni HB, Ksantini M, M’rad R, Kharrat M, Chaabouni M, Maazoul F et al. MEFV Mutations in Tunisian Patients Suffering from Familial Mediterranean Fever. Semin Arthritis Rheum 2007; 36: 397-401.
- 9. Mattit H, Joma M, Al-Cheikh S, El-Khateeb M, Medlej-Hashim M, Salem N, Delague V et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 2006; 49: 481-486.
- 10. Belmahi L, Sefiani A, Fouveau C, Feingold J, Delpech M, Grateau G et al. Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. C R Biol 2006; 329: 71-74.
- 11. Majeed HA, El-Khateeb M, El-Shanti H, Rabaiha ZA, Tayeh M, Najib D. The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. Semin Arthritis Rheum 2005; 34: 813-818.
- 12. Medlej-Hashim M, Rawashdeh M, Chouery E, Mansour I, Delague V, Lefranc G et al. Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat 2000; 15: 384.
- 13. Akar N, Akar E, Özel D, Tekin M, Ekim M, Yalçınkaya F. A note on mutation analysis in familial Mediterranean fever. Pediatr Nephrol 2003; 18: 196-197.
- 14. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Human Mutat 2000; 15: 118-119.
- 15. Al-Alami JR, Tayeh MK, Najib DA, Abu Rubaiha ZH, Majeed HA, AlKhateeb MS et al. Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med J 2003; 24: 1055-1059.
- 16. Settin A, El-Baz R, AbdRasool M, El-Khalegy H, Elsayed O, ElBendary M et al. Clinical and molecular diagnosis of familial Mediterranean fever in Egyptian children. J Gastrointest Liver Dis. 2007; 16: 141-145.
- 17. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999; 103: e70.
- 18. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-483.
- 19. Touitou I, Touitou I, Magne X, Molinari N, Navarro A, Quellec AL et al. MEFV mutations in Behcet’s disease. Hum Mutat 2000; 16: 271-272.
- 20. Akar N, Ozturk A, Ozel D, Akar E, Ekim M. Is MEFV P706 polymorphism important in familial Mediterranean fever patients? J Nephrol 2006; 19: 119-120.
- 21. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, Kartalis G, Speletas M, Ritis K. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 2007; 71: 458-467.
- 22. Öztürk A, Ocakar B, Ekim M, Akar N. Is MEFV gene Arg202Gln (605G>A) a disease-causin mutation? Turk J Med Sci 2008; 38: 205-208.
- 23. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the Pyrin gene. Scand J Rheumatol 1998; 27: 92- 97.
- 24. Yalcinkaya F, Cakar N, Misirhoglu M, Tumer N, Akar N, Tekin M et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutationindependent amyloidosis. Rheumatology 2000; 39: 67-72.
- 25. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M et al. Familial Mediterranean Fever: Effect of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000; 105: E70.
- 26. Mokhtar MM, Abdel-Fattah MM. Consanguinity and advanced maternal age as risk factors for reproductive losses in Alexandria, Egypt. Eur J Epidemiol 200; 17: 559-565.